Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group

G. J. Cuchural; F. P. Tally; N. V. Jacobus; T. Cleary; S. M. Finegold; G. Hill; P. Iannini; J. P. O'Keefe; C. Pierson

doi:10.1128/AAC.34.3.479

Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group

G. J. Cuchural, F. P. Tally, N. V. Jacobus, T. Cleary, S. M. Finegold, G. Hill, P. Iannini, J. P. O'Keefe, C. Pierson

Pathology

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Abstract

A nationwide susceptibility survey of 557 isolates of the Bacteroides fragilis group was continued in 1986. The most active β-lactam drugs were imipenem and ticarcillin-clavulanic acid, which had 0.2 and 1.7% resistance, respectively. The rank order of activity of β-lactam drugs was imipenem, tricarcillin-clavulanic acid, cefoxitin, piperacillin, moxalactam, ceftizoxime, cefotetan, cefotaxime, cefoperazone, and ceftazadime.

Original language	English (US)
Pages (from-to)	479-480
Number of pages	2
Journal	Antimicrobial agents and chemotherapy
Volume	34
Issue number	3
DOIs	https://doi.org/10.1128/AAC.34.3.479
State	Published - 1990

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.34.3.479

Fingerprint Dive into the research topics of 'Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group'. Together they form a unique fingerprint.

Cite this

Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group. / Cuchural, G. J.; Tally, F. P.; Jacobus, N. V.; Cleary, T.; Finegold, S. M.; Hill, G.; Iannini, P.; O'Keefe, J. P.; Pierson, C.

In: Antimicrobial agents and chemotherapy, Vol. 34, No. 3, 1990, p. 479-480.

Research output: Contribution to journal › Article › peer-review

@article{02805441b4484fccb867bae4ac79a920,

title = "Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group",

abstract = "A nationwide susceptibility survey of 557 isolates of the Bacteroides fragilis group was continued in 1986. The most active β-lactam drugs were imipenem and ticarcillin-clavulanic acid, which had 0.2 and 1.7% resistance, respectively. The rank order of activity of β-lactam drugs was imipenem, tricarcillin-clavulanic acid, cefoxitin, piperacillin, moxalactam, ceftizoxime, cefotetan, cefotaxime, cefoperazone, and ceftazadime.",

author = "Cuchural, {G. J.} and Tally, {F. P.} and Jacobus, {N. V.} and T. Cleary and Finegold, {S. M.} and G. Hill and P. Iannini and O'Keefe, {J. P.} and C. Pierson",

year = "1990",

doi = "10.1128/AAC.34.3.479",

language = "English (US)",

volume = "34",

pages = "479--480",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "3",

}

TY - JOUR

T1 - Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group

AU - Cuchural, G. J.

AU - Tally, F. P.

AU - Jacobus, N. V.

AU - Cleary, T.

AU - Finegold, S. M.

AU - Hill, G.

AU - Iannini, P.

AU - O'Keefe, J. P.

AU - Pierson, C.

PY - 1990

Y1 - 1990

N2 - A nationwide susceptibility survey of 557 isolates of the Bacteroides fragilis group was continued in 1986. The most active β-lactam drugs were imipenem and ticarcillin-clavulanic acid, which had 0.2 and 1.7% resistance, respectively. The rank order of activity of β-lactam drugs was imipenem, tricarcillin-clavulanic acid, cefoxitin, piperacillin, moxalactam, ceftizoxime, cefotetan, cefotaxime, cefoperazone, and ceftazadime.

AB - A nationwide susceptibility survey of 557 isolates of the Bacteroides fragilis group was continued in 1986. The most active β-lactam drugs were imipenem and ticarcillin-clavulanic acid, which had 0.2 and 1.7% resistance, respectively. The rank order of activity of β-lactam drugs was imipenem, tricarcillin-clavulanic acid, cefoxitin, piperacillin, moxalactam, ceftizoxime, cefotetan, cefotaxime, cefoperazone, and ceftazadime.

UR - http://www.scopus.com/inward/record.url?scp=0025098816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025098816&partnerID=8YFLogxK

U2 - 10.1128/AAC.34.3.479

DO - 10.1128/AAC.34.3.479

M3 - Article

C2 - 2334161

AN - SCOPUS:0025098816

VL - 34

SP - 479

EP - 480

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 3

ER -